• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.17%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    2.04 Down 0.02(0.97%) May 28, 4:03PM EDT
    Add to Portfolio
    Prev Close:2.06
    Open:2.05
    Bid:1.00 x 200
    Ask:2.65 x 800
    1y Target Est:2.60
    Beta:-0.18
    Earnings Date:Jul 15 - Jul 22 (Est.)
    Day's Range:2.02 - 2.14
    52wk Range:1.53 - 4.20
    Volume:1,029,178
    Avg Vol (3m):317,761
    Market Cap:190.16M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PLX

    Comparison

    Symbol% ChgMkt Cap
    PLXDown 0.97%190.16M
    SHPGUp 0.67%51.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.32
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.28

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback